Sonelokimab Antibody
Sonelokimab (ALX 0761) is a trivalent nanobody therapeutic candidate that simultaneously inhibits the pro-inflammatory cytokines IL-17A and IL-17F. It is being investigated for the treatment of plaque psoriasis, with research encompassing both in vitro mechanistic studies and in vivo preclinical models of autoimmune disease.
Product Specifications
Target
MMP, Interleukin
Conjugation
Unconjugated
Field of Research
Immunology & Inflammation, Protein Biochemistry
Storage Conditions
Maintain refrigerated at 2-8°C for up to 2 weeks. For long term storage store at -20°C in small aliquots to prevent freeze-thaw cycles.
Notes
For research use only.
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
